Newly released market study: Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019

Non-small cell lung cancer occurs when normal cells grow and multiply without control after undergoing a cell transformation. Lung cancer is the leading cause of cancer deaths worldwide, and the incidence of lung cancer is increasing significantly. Lung cancer is the common cause of mortality and morbidity not only in developed countries but also in developing countries. One of the most common types of lung cancer is non-small cell lung cancer. It grows and spreads quite slowly. Smoking is considered as a major cause of lung cancer, although lung cancer also occurs in non-smokers. There are three main types of non-small cell lung cancer: squamous cell (epidermoid) carcinoma, adenocarcinoma, and large cell (undifferentiated) carcinoma. Some of the common symptoms associated with non-small cell lung cancer are chest pain, a cough that does not go away, coughing up blood, fatigue, loss of appetite, losing weight without trying, shortness of breath, and wheezing.

Full Report Details at
- http://www.fastmr.com/prod/1063646_global_nonsmall_cell_lung.aspx?afid=302

Technavio's analysts forecast the global non-small cell lung cancer therapeutics market to grow at a CAGR of 6.77% over the period 2014-2019.

Covered in this report
The report covers the current scenario and the growth prospects of the global non-small cell lung cancer therapeutics market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of various drugs used for the treatment of non-small cell lung cancer.

Technavio's report, Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and Europe; it also covers the landscape of the global non-small cell lung cancer therapeutics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

* Americas
* APAC
* Europe

Key Vendors

* AstraZeneca
* Celgene
* Eli Lilly
* F. Hoffmann-La Roche
* Pfizer

Other Prominent Vendors

* Abbvie
* Aetna
* Agennix
* Amgen
* BetaPharma
* Bionumerik Pharmaceuticals
* Boehringer Ingelheim
* Bristol-Myers Squibb
* CBT Pharma
* Celldex Therapeutics
* Dainippon Pharma
* Eisai Pharmaceuticals
* GlaxoSmithKline
* Helsinn
* IMClone Systems
* IsisPharma
* Kadmon
* Kyowa Hakko Kirin
* MabVax Therapeutics
* Merck
* Novartis
* OncoGenex
* OSI Pharmaceuticals
* Peregrine
* Pierre Fabre
* Qiagen
* Sanofi
* Synta Pharmaceuticals
* Teva Pharmaceuticals

Key Market Drivers

* Promising drug pipeline
* For a full, detailed list, view our report

Key Market Challenges

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Global Lung Cancer Therapeutics Market 2015-2019
- Non-Small Cell Lung Cancer - Pipeline Review, H1 2015
- Global Small Cell Lung Cancer Therapeutics Market 2015-2019
- Islet Cell Carcinoma (Insulinoma) Global Clinical Trials Review, H1, 2015
- Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015